期刊
JOURNAL OF BIOMOLECULAR NMR
卷 74, 期 10-11, 页码 565-577出版社
SPRINGER
DOI: 10.1007/s10858-020-00321-1
关键词
Screening; Fragments based drug discovery; NMR; FBDD; CCPN; CcpNmr software
资金
- MRC-IMPACT PhD programme [MR/NO13913/1]
- MRC [MR/L000555/1, MR/P00038X/1]
- MRC [MR/L000555/1, MR/P00038X/1] Funding Source: UKRI
Fragment-based drug discovery or FBDD is one of the main methods used by industry and academia for identifying drug-like candidates in early stages of drug discovery. NMR has a significant impact at any stage of the drug discovery process, from primary identification of small molecules to the elucidation of binding modes for guiding optimisations. The essence of NMR as an analytical tool, however, requires the processing and analysis of relatively large amounts of single data items, e.g. spectra, which can be daunting when managed manually. One bottleneck in FBDD by NMR is a lack of adequate and well-integrated resources for NMR data analysis that are freely available to the community. Thus, scientists typically resort to manually inspecting large datasets and relying predominantly on subjective interpretations. In this manuscript, we present CcpNmr AnalysisScreen, a software package that provides computational tools for automated analysis of FBDD data by NMR. We outline how the quality of collected spectra can be evaluated quickly, and how robust workflows can be optimised for reliable and rapid hit identification. With an intuitive graphical user interface and powerful algorithms, AnalysisScreen enables easy analysis of the large datasets needed in the early process of drug discovery by NMR.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据